<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tblu10" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Groups</th><th>Cell line</th><th>Variance estimate</th><th>F test statistic <break/>Fc<sub>(1,16)</sub></th><th>Partial &#951;<sup>2</sup></th><th>Effect size <italic>f</italic></th><th>A priori power</th><th>Total sample size <break/>(8 groups)</th></tr></thead><tbody><tr><td rowspan="4">DMSO vs. PD184352 <break/>and sorafenib</td><td>D04</td><td>2%</td><td>223.55</td><td>0.9332</td><td>3.7379</td><td>90.2%</td><td>10</td></tr><tr><td>D04</td><td>15%</td><td>3.9741</td><td>0.1990</td><td>0.4984</td><td>80.4%</td><td>46</td></tr><tr><td>D04</td><td>28%</td><td>1.1405</td><td>0.0665</td><td>0.2670</td><td>80.0%</td><td>150</td></tr><tr><td>D04</td><td>40%</td><td>0.5589</td><td>0.0337</td><td>0.1869</td><td>80.0%</td><td>303</td></tr><tr><td rowspan="4">DMSO vs. 885A</td><td>D04</td><td>2%</td><td>3580.31</td><td>0.9955</td><td>14.959</td><td>99.9%</td><td>10</td></tr><tr><td>D04</td><td>15%</td><td>63.6498</td><td>0.7991</td><td>1.9945</td><td>84.0%</td><td>11</td></tr><tr><td>D04</td><td>28%</td><td>18.2668</td><td>0.5331</td><td>1.0685</td><td>80.8%</td><td>15</td></tr><tr><td>D04</td><td>40%</td><td>8.9507</td><td>0.3587</td><td>0.7479</td><td>80.1%</td><td>23</td></tr></tbody></table></table-wrap>